These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE. Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888 [TBL] [Abstract][Full Text] [Related]
9. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis. Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613 [TBL] [Abstract][Full Text] [Related]
10. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia. Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868 [TBL] [Abstract][Full Text] [Related]
11. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052 [TBL] [Abstract][Full Text] [Related]
12. A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE families. Straumann A; Blanchard C; Radonjic-Hoesli S; Bussmann Ch; Hruz P; Safroneeva E; Simon D; Schoepfer AM; Simon HU Allergy; 2016 Jun; 71(6):889-900. PubMed ID: 26970242 [TBL] [Abstract][Full Text] [Related]
14. Targeting AMCase reduces esophageal eosinophilic inflammation and remodeling in a mouse model of egg induced eosinophilic esophagitis. Cho JY; Rosenthal P; Miller M; Pham A; Aceves S; Sakuda S; Broide DH Int Immunopharmacol; 2014 Jan; 18(1):35-42. PubMed ID: 24239745 [TBL] [Abstract][Full Text] [Related]
15. [Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center]. Ahn B; Lee DH; Lee CM; Hwang JJ; Yoon H; Shin CM; Park YS; Kim N Korean J Gastroenterol; 2016 Apr; 67(4):178-82. PubMed ID: 27112243 [TBL] [Abstract][Full Text] [Related]
16. Primary eosinophilic esophagitis in children and adults: new aspects for diagnosis. Bordea MA; Samaşca G; Cristea V; Miu N Rom J Intern Med; 2013; 51(2):92-5. PubMed ID: 24294812 [TBL] [Abstract][Full Text] [Related]
17. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice. Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775 [TBL] [Abstract][Full Text] [Related]
18. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Clayton F; Fang JC; Gleich GJ; Lucendo AJ; Olalla JM; Vinson LA; Lowichik A; Chen X; Emerson L; Cox K; O'Gorman MA; Peterson KA Gastroenterology; 2014 Sep; 147(3):602-9. PubMed ID: 24907494 [TBL] [Abstract][Full Text] [Related]
19. A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time. Greuter T; Straumann A; Fernandez-Marrero Y; Germic N; Hosseini A; Chanwangpong A; Yousefi S; Simon D; Collins MH; Bussmann C; Chehade M; Dellon ES; Furuta GT; Gonsalves N; Hirano I; Moawad FJ; Biedermann L; Safroneeva E; Schoepfer AM; Simon HU Clin Transl Gastroenterol; 2024 Apr; 15(4):e00664. PubMed ID: 38318864 [TBL] [Abstract][Full Text] [Related]
20. Comparison of eotaxin-3 biomarker in patients with eosinophilic oesophagitis, proton pump inhibitor-responsive oesophageal eosinophilia and gastro-oesophageal reflux disease. Moawad FJ; Wells JM; Johnson RL; Reinhardt BJ; Maydonovitch CL; Baker TP Aliment Pharmacol Ther; 2015 Jul; 42(2):231-8. PubMed ID: 26011446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]